InspireMD Inc (NSPR) - Product Pipeline Analysis, 2019 Update
November 2019
34
About the Report
About the Report
Summary
InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction, and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InspireMD Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
InspireMD Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
InterCure Ltd
Etropal Ad
Bioiasis AD Sofia
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
InspireMD Inc Company Overview
InspireMD Inc Company Snapshot
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc-Pipeline Analysis Overview
InspireMD Inc-Key Facts
InspireMD Inc-Major Products and Services
InspireMD Inc Pipeline Products by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Pipeline Products Overview
CGuard Embolic Prevention System
CGuard Embolic Prevention System Product Overview
CGuard Embolic Prevention System Clinical Trial
MGuard Drug Eluting Stent
MGuard Drug Eluting Stent Product Overview
Next Gen CGuard-5F
Next Gen CGuard-5F Product Overview
NGuard
NGuard Product Overview
PVGuard
PVGuard Product Overview
RGuard Renal
RGuard Renal Product Overview
InspireMD Inc-Key Competitors
InspireMD Inc-Key Employees
InspireMD Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InspireMD Inc, Recent Developments
Sep 09, 2019: InspireMD provides business update
Aug 06, 2019: InspireMD announces second quarter 2019 financial results
May 14, 2019: InspireMD reports first quarter 2019 financial results
Feb 19, 2019: InspireMD announces fourth quarter 2018 financial results
Jan 24, 2019: InspireMD announces presentation of interim data from investigator-initiated study comparing CGuard EPS with a conventional open-cell carotid stent
Jan 23, 2019: InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2019
Jan 22, 2019: InspireMD announces results from initial clinical study of the CGuard Embolic Prevention System (EPS) with SmartFit technology
Jan 18, 2019: InspireMD's CGuard Embolic Prevention System to be prominently featured in live case transmissions at LINC
Jan 14, 2019: InspireMD Announces the Distribution of CGuard Embolic Prevention System in South Africa
Jan 11, 2019: InspireMD receives noncompliance notice from NYSE American
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
InspireMD Inc Pipeline Products by Equipment Type
InspireMD Inc Pipeline Products by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
List of Table
List of Tables
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc Pipeline Products by Equipment Type
InspireMD Inc Pipeline Products by Indication
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc, Key Facts
InspireMD Inc, Major Products and Services
InspireMD Inc Number of Pipeline Products by Development Stage
InspireMD Inc Pipeline Products Summary by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Ongoing Clinical Trials Summary
CGuard Embolic Prevention System-Product Status
CGuard Embolic Prevention System-Product Description
CGuard Embolic Prevention System-A Multicenter Italian Registry of Real World CAS with C-Guard Mesh Covered Stent: The IRONGUARD 2 Study
CGuard Embolic Prevention System-Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink) Versus the Mesh Covered Stent (CGuard): The SIBERIA Trial
CGuard Embolic Prevention System-Prospective Evaluation of All-comer Percutaneous Carotid Revascularization In Symptomatic and Increased-risk Asymptomatic Carotid Artery Stenosis
MGuard Drug Eluting Stent-Product Status
MGuard Drug Eluting Stent-Product Description
Next Gen CGuard-5F-Product Status
Next Gen CGuard-5F-Product Description
NGuard-Product Status
NGuard-Product Description
PVGuard-Product Status
PVGuard-Product Description
RGuard Renal-Product Status
RGuard Renal-Product Description
InspireMD Inc, Key Employees
InspireMD Inc, Other Locations
InspireMD Inc, Subsidiaries
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.